Communiqués

18/11 Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits PR
16/05/24 Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products AQ
16/05/24 Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K PU
05/10/23 Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area AQ
02/10/23 Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise AQ
08/08/23 Panacea Life Sciences Holdings, Inc. Celebrates National CBD Day (August 8th) By Shifting To An “Everyday Low Pricing Model” To Meet Customer Needs AQ
02/08/23 Panacea Life Sciences Holdings, Inc. Continues Pursuit of High Growth Health and Wellness Products with Acquisition of Sierra Sage, LLC and Halucenex from Melodial Global Health (formerly Creso Pharma Limited) AQ
20/07/23 Panacea Life Sciences Holdings, Inc. Announces CBD/CBG Clinical Trial Findings for the Management of Irritable Bowel Symptoms AQ
18/07/23 Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast NE
10/07/23 Panacea Life Sciences Holdings, Inc. Enters Into Agreement to Natural Health and Wellness Chain of Retail Locations in Tampa, Florida AQ
07/07/23 Panacea Life Sciences Holdings, Inc. Adopts Diversification Plan: Vegan, Organic, Nutraceuticals, Alternative Health and Wellness Products and Investigative Research Plans for Psylocibin and other Psychedelics. AQ
15/06/23 Panacea Life Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K. AQ
02/06/23 PANACEA LIFE SCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) AQ
20/04/23 Panacea Life Sciences Holdings, Inc. Discusses Acquisition Strategy and International Expansion with The Stock Day Podcast NE
19/04/23 Panacea Life expands CBD business into Guyana, South America to capitalize on the country’s rapid growth AQ
04/04/23 Panacea Life Sciences Holdings, Inc. Discusses 100% Customer Base Increase and 2023 Goals with The Stock Day Podcast NE
30/03/23 PANACEA LIFE SCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-K) AQ
27/03/23 PANACEA’S MANUFACTURING DIVISION INCREASES ITS CUSTOMER BASE BY 100%. IN FIRST QUARTER 2023 AQ
14/02/23 PANACEA LIFE SCIENCES HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K) AQ
23/01/23 PANACEA LIFE SCIENCES HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) AQ
23/01/23 Panacea Announces Letter of Intent to Acquire N7 Enterprises, Inc. AQ
27/12/22 PANACEA LIFE SCIENCES HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K) AQ
14/11/22 PANACEA LIFE SCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q) AQ
26/10/22 Revolutionary progress made in the inaugural year of the Panacea Cannabinoid Research Center at Colorado State University GL
26/10/22 Revolutionary progress made in the inaugural year of the Panacea Cannabinoid Research Center at Colorado State University GL
Aucun résultat pour cette recherche